Determination of the anti-platelet-activating factor BN-50727 and its metabolites in human plasma by high-performance liquid chromatography-solid-phase extraction
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-06-23
著者
-
Obach R.
S.a. Lasa Laboratorios Pharmacokinetic Department
-
Obach R.
Pharmacokinetics Pharmacodynamics And Drug Metabolism Global Research And Development Pfizer Inc.
-
PRUNONOSA J.
S.A. Lasa Laboratorios, Pharmacokinetic Department
-
PRUNONOSA J.
Pharmacokinetic Department, S.A. Lasa Laboratorios
-
PARERA L.
Pharmacokinetic Department, S.A. Lasa Laboratorios
-
PERAIRE C.
Pharmacokinetic Department, S.A. Lasa Laboratorios
-
PLA F.
Pharmacokinetic Department, S.A. Lasa Laboratorios
-
LAVERGNE O.
Pharmacokinetic Department, S.A. Lasa Laboratorios
-
Peraire C.
S.a. Lasa Laboratorios Pharmacokinetic Department
-
Prunonosa J.
S.a. Lasa Laboratorios Pharmacokinetic Department
-
Parera L.
Pharmacokinetic Department S.a. Lasa Laboratorios
関連論文
- In Vitro Metabolism of CP-122, 721 ((2S,3S)-2-Phenyl-3-[(5-Trifluoromethoxy-2-Methoxy)Benzylamino]Piperidine), a Non-Peptide Antagonist of the Substance P Receptor
- Determination of the anti-platelet-activating factor BN-50727 and metabolites in human urine by high-performance liquid chromatography using solid-phase extraction
- Determination of the anti-platelet-activating factor BN-50727 and its metabolites in human plasma by high-performance liquid chromatography-solid-phase extraction